以腹痛為主訴的軀體化障礙誤診為腹型癲癇一例_Journal of Epilepsy

Authors：

孫歡 ¹ ,  楊輝 ^1,2

1. ;
2. ;

Corresponding?author：

楊輝, Email: yhuihui2004@163.com

Keywords：

DOI：

10.7507/2096-0247.202204015

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 孫歡, 楊輝. 以腹痛為主訴的軀體化障礙誤診為腹型癲癇一例. Journal of Epilepsy, 2022, 8(4): 379-381. doi: 10.7507/2096-0247.202204015 Copy

1.	張雅楠, 金超, 寧亮, 等. 綜合醫院心內科門診心理障礙患者軀體化癥狀臨床特征及相關因素. 中華心血管病雜志, 2019, (11): 907-912.
2.	楊程惠, 周波, 周凡, 等. 軀體癥狀障礙患者疾病認知現狀及影響因素分析. 中國全科醫學, 2020, 23(32): 4039-4046.
3.	Hüsing P, L?we B, Toussaint A. Comparing the diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic. J Psychosom Res, 2018, 113: 74-80.
4.	Rossetti M G, Delvecchio G, Calati R, et al. Structural neuroimaging of somatoform disorders: a systematic review. Neurosci Biobehav Rev, 2021, 122: 66-78.
5.	Zhao K, Liu H, Yan R, et al. Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms. Brain Behav, 2017, 7(8): e00754.
6.	Zhao J, Su Q, Liu F, et al. Regional white matter volume abnormalities in first-episode somatization disorder. Int J Psychophysiol, 2018, 133: 12-16.
7.	Ye Q, Yan D, Yao M, et al. Hyperexcitability of cortical oscillations in patients with somatoform pain disorder: a resting-state eeg study. Neural Plast, 2019, 19: 2687150.
8.	閆棟. 軀體化疼痛障礙患者EEG改變及相關骨骼肌衰老機制研究. 南方醫科大學, 2020, 博士學位論文: 1-60.
9.	Edgcomb J B, Kerner B. Predictors and outcomes of somatization in bipolar I disorder: a latent class mixture modeling approach. J Affect Disord, 2018, 227: 681-687.
10.	Hayashida A, Tomizawa Y, Nakahara T, et al. Abdominal Epilepsy associated with alzheimer's disease. J Am Geriatr Soc, 2016, 64(5): 1146-7.
11.	肖秀珍, 歐陽遠寒, 宋治, 等. 癲癇發病中突觸機制的研究進展. 中南大學學報:醫學版, 2018, 43(1): 90-94.
12.	孟令章, 柴一峰. 腹型癲癇案. 世界最新醫學信息文摘, 2019, 19(6): 269.
13.	董香麗, 孫偉銘, 袁也豐. 軀體化障礙患者家屬焦慮情緒及影響因素分析. 現代預防醫學, 2016, 43(7): 1253-1256.
14.	王發榮. 丁苯酞軟膠囊在基底動脈尖綜合征治療中的應用效果. 臨床醫學研究與實踐, 2018, 3(35): 33-34.
15.	李奕男, 楊曉樂. 中藥熏蒸療法聯合度洛西汀治療軀體化障礙患者的臨床觀察. 國際精神病學雜志, 2021, 48(4): 667-669.
16.	袁春媛. 小劑量抗精神病藥聯合心理療法治療軀體化障礙的臨床效果. 世界復合醫學, 2021, 7(10): 166-170.
17.	趙蔚, 胡全喜, 張秀蓮. 小劑量抗精神病藥聯合心理療法治療軀體化障礙的療效觀察. 中國實用醫藥, 2020, 15(6): 157-159.
18.	饒貴優, 林燕. 小劑量抗精神病藥聯合心理療法治療軀體化障礙的療效觀察. 數理醫藥學雜志, 2020, 33(4): 594-595.

1. 張雅楠, 金超, 寧亮, 等. 綜合醫院心內科門診心理障礙患者軀體化癥狀臨床特征及相關因素. 中華心血管病雜志, 2019, (11): 907-912.
2. 楊程惠, 周波, 周凡, 等. 軀體癥狀障礙患者疾病認知現狀及影響因素分析. 中國全科醫學, 2020, 23(32): 4039-4046.
3. Hüsing P, L?we B, Toussaint A. Comparing the diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic. J Psychosom Res, 2018, 113: 74-80.
4. Rossetti M G, Delvecchio G, Calati R, et al. Structural neuroimaging of somatoform disorders: a systematic review. Neurosci Biobehav Rev, 2021, 122: 66-78.
5. Zhao K, Liu H, Yan R, et al. Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms. Brain Behav, 2017, 7(8): e00754.
6. Zhao J, Su Q, Liu F, et al. Regional white matter volume abnormalities in first-episode somatization disorder. Int J Psychophysiol, 2018, 133: 12-16.
7. Ye Q, Yan D, Yao M, et al. Hyperexcitability of cortical oscillations in patients with somatoform pain disorder: a resting-state eeg study. Neural Plast, 2019, 19: 2687150.
8. 閆棟. 軀體化疼痛障礙患者EEG改變及相關骨骼肌衰老機制研究. 南方醫科大學, 2020, 博士學位論文: 1-60.
9. Edgcomb J B, Kerner B. Predictors and outcomes of somatization in bipolar I disorder: a latent class mixture modeling approach. J Affect Disord, 2018, 227: 681-687.
10. Hayashida A, Tomizawa Y, Nakahara T, et al. Abdominal Epilepsy associated with alzheimer's disease. J Am Geriatr Soc, 2016, 64(5): 1146-7.
11. 肖秀珍, 歐陽遠寒, 宋治, 等. 癲癇發病中突觸機制的研究進展. 中南大學學報:醫學版, 2018, 43(1): 90-94.
12. 孟令章, 柴一峰. 腹型癲癇案. 世界最新醫學信息文摘, 2019, 19(6): 269.
13. 董香麗, 孫偉銘, 袁也豐. 軀體化障礙患者家屬焦慮情緒及影響因素分析. 現代預防醫學, 2016, 43(7): 1253-1256.
14. 王發榮. 丁苯酞軟膠囊在基底動脈尖綜合征治療中的應用效果. 臨床醫學研究與實踐, 2018, 3(35): 33-34.
15. 李奕男, 楊曉樂. 中藥熏蒸療法聯合度洛西汀治療軀體化障礙患者的臨床觀察. 國際精神病學雜志, 2021, 48(4): 667-669.
16. 袁春媛. 小劑量抗精神病藥聯合心理療法治療軀體化障礙的臨床效果. 世界復合醫學, 2021, 7(10): 166-170.
17. 趙蔚, 胡全喜, 張秀蓮. 小劑量抗精神病藥聯合心理療法治療軀體化障礙的療效觀察. 中國實用醫藥, 2020, 15(6): 157-159.
18. 饒貴優, 林燕. 小劑量抗精神病藥聯合心理療法治療軀體化障礙的療效觀察. 數理醫藥學雜志, 2020, 33(4): 594-595.

Previous Article
首發為帕金森癥狀的抗GAD65抗體綜合征一例

Journal of Epilepsy

以腹痛為主訴的軀體化障礙誤診為腹型癲癇一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content